GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Biotherapeutics Inc (FRA:PSH0) » Definitions » E10

Sernova Biotherapeutics (FRA:PSH0) E10 : €-0.04 (As of Apr. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sernova Biotherapeutics E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sernova Biotherapeutics's adjusted earnings per share data for the three months ended in Apr. 2025 was €-0.006. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.04 for the trailing ten years ended in Apr. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sernova Biotherapeutics was 9.10% per year. The lowest was -10.10% per year. And the median was 7.20% per year.

As of today (2025-07-18), Sernova Biotherapeutics's current stock price is €0.108. Sernova Biotherapeutics's E10 for the quarter that ended in Apr. 2025 was €-0.04. Sernova Biotherapeutics's Shiller PE Ratio of today is .


Sernova Biotherapeutics E10 Historical Data

The historical data trend for Sernova Biotherapeutics's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Biotherapeutics E10 Chart

Sernova Biotherapeutics Annual Data
Trend Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23 Oct24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -0.03 -0.03 -0.04

Sernova Biotherapeutics Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.04 -0.04 -0.04 -0.04 -0.04

Competitive Comparison of Sernova Biotherapeutics's E10

For the Biotechnology subindustry, Sernova Biotherapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova Biotherapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova Biotherapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sernova Biotherapeutics's Shiller PE Ratio falls into.


;
;

Sernova Biotherapeutics E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sernova Biotherapeutics's adjusted earnings per share data for the three months ended in Apr. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Apr. 2025 (Change)*Current CPI (Apr. 2025)
=-0.006/129.1809*129.1809
=-0.006

Current CPI (Apr. 2025) = 129.1809.

Sernova Biotherapeutics Quarterly Data

per share eps CPI Adj_EPS
201507 -0.003 100.579 -0.004
201510 -0.007 100.500 -0.009
201601 -0.003 100.184 -0.004
201604 -0.003 101.370 -0.004
201607 -0.007 101.844 -0.009
201610 -0.003 102.002 -0.004
201701 -0.001 102.318 -0.001
201704 -0.003 103.029 -0.004
201707 -0.003 103.029 -0.004
201710 -0.007 103.424 -0.009
201801 -0.003 104.056 -0.004
201804 -0.006 105.320 -0.007
201807 -0.007 106.110 -0.009
201810 0.000 105.952 0.000
201901 -0.003 105.557 -0.004
201904 -0.003 107.453 -0.004
201907 -0.007 108.243 -0.008
201910 -0.007 107.927 -0.008
202001 -0.007 108.085 -0.008
202004 -0.007 107.216 -0.008
202007 -0.006 108.401 -0.007
202010 0.000 108.638 0.000
202101 -0.006 109.192 -0.007
202104 -0.007 110.851 -0.008
202107 -0.007 112.431 -0.008
202110 0.000 113.695 0.000
202201 -0.014 114.801 -0.016
202204 -0.015 118.357 -0.016
202207 -0.015 120.964 -0.016
202210 -0.022 121.517 -0.023
202301 -0.021 121.596 -0.022
202304 -0.020 123.571 -0.021
202307 -0.021 124.914 -0.022
202310 -0.028 125.310 -0.029
202401 -0.021 125.072 -0.022
202404 -0.020 126.890 -0.020
202407 -0.013 128.075 -0.013
202410 -0.007 127.838 -0.007
202501 -0.013 127.443 -0.013
202504 -0.006 129.181 -0.006

Add all the adjusted EPS together and divide 10 will get our e10.


Sernova Biotherapeutics  (FRA:PSH0) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sernova Biotherapeutics E10 Related Terms

Thank you for viewing the detailed overview of Sernova Biotherapeutics's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova Biotherapeutics Business Description

Traded in Other Exchanges
Address
700 Collip Circle, Suite 114, London, ON, CAN, N6G 4X8
Sernova Biotherapeutics Inc is a clinical-stage company developing regenerative medicines. The company develops Cell Pouch with human donor cells or stem cells to create a biohybrid organ. The Cell Pouch is a implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones, or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Sernova Biotherapeutics Headlines

No Headlines